Results 21 to 30 of about 6,167,214 (176)

Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults:2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK [PDF]

open access: yes, 2010
The identification and management of adults presenting with pneumonia is a major challenge for primary care health professionals. This paper summarises the key recommendations of the British Thoracic Society (BTS) Guidelines for the management of ...
Woodhead, Mark A   +10 more
core   +1 more source

Clinical Comparative Study of Sulbactam/Ampicillin and Imipenem/Cilastatin in Elderly Patients with Community-Acquired Pneumonia [PDF]

open access: yes, 2006
Objective: To evaluate the clinical usefulness of sulbactam/ampicillin therapy for community-acquired pneumonia in the elderly. Methodology: A randomized prospective clinical study was conducted in the elderly patients with moderate-to-severe community ...
Higashiyama, Yasuhito   +10 more
core   +1 more source

The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. [PDF]

open access: yes, 2013
BACKGROUND: Emerging epidemiological evidence suggests that statins may reduce the risk of community-acquired pneumonia (CAP) and its complications. PURPOSE: Performed a systematic review to address the role of statins in the prevention or treatment ...
Imad M Tleyjeh   +39 more
core   +1 more source

Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study [PDF]

open access: yes, 2012
To examine whether acute dysglycaemia predicts death in people admitted to hospital with community acquired ...
Rohde, Gernot   +28 more
core   +2 more sources

Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article

open access: yesMedical Sciences, 2021
Community-acquired pneumonia is still a major cause of morbidity and mortality worldwide. Since the inflammatory response induced by the immune system is often a major contributor to the lung injury, it becomes reasonable to assess the potential benefit ...
Faeq R. Kukhon, Emir Festic
doaj   +1 more source

Legionnaires' Disease - Results of a Multicenter Canadian Study

open access: yesCanadian Journal of Infectious Diseases, 2003
BACKGROUND: There has never been a cross-Canada surveillance project to determine the rate of Legionella species as a cause of community-acquired pneumonia requiring hospitalization and to determine whether there are any regional differences in the rates
Thomas J Marrie   +4 more
doaj   +1 more source

Community-acquired viral pneumonia in human immunodeficiency virus infected patients [PDF]

open access: yes, 2019
Respiratory viruses (RV) have become an important cause of community-acquired pneumonia in immunocompromised patients with the highest rates of morbidity and mortality.
Cillóniz, Catia   +3 more
core   +2 more sources

ETIOLOGICAL FEATURES AND ANTIMICROBIAL RESISTANCE IN HEALTHCARE-ASSOCIATED PNEUMONIA

open access: yesArta Medica, 2020
Objectives. Healthcare-associated pneumonia develops in patients undergoing regular medical procedures or has a longterm contact with the hospital environment. Several studies have shown important differences in healthcare-associated pneumonia, comparing
Cristina Toma   +2 more
doaj   +1 more source

A Clinical Comparative Study of Piperacillin and Sulbactam/Ampicillin in Patients with Community-Acquired Bacterial Pneumonia [PDF]

open access: yes, 2009
Objective To evaluate the clinical usefulness of piperacillin (4 g/day) therapy for community-acquired pneumonia compared to sulbactam/ampicillin (6 g/day).
Higashiyama, Yasuhito   +10 more
core   +1 more source

The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia

open access: yes, 2006
SETTING: A total of 33 hospitals in 13 countries in North America, Europe, Africa, Asia and Latin America. OBJECTIVE: To investigate the relationship between the pneumonia severity index (PSI) and the time to clinical stability from intravenous to oral ...
A. LaJoie   +16 more
core   +2 more sources

Home - About - Disclaimer - Privacy